Hippie Flip: Difference between revisions
From BurnZero
(Created page with " '''Co-use of 3,4-Methylenedioxy methamphetamine (MDMA) with psilocybin / magic mushrooms is termed ''hippy flipping''.''' It is thought that by combining MDMA with psilocybin this may reduce challenging experiences and enhances positive experiences associated with the medicine. Some evidence points to the use of low dose MDMA (50–75 mg) with psilocybin associates with significantly lower levels of total challenging experie...") |
mNo edit summary |
||
| Line 1: | Line 1: | ||
'''Co-use of 3,4-Methylenedioxy methamphetamine ([[MDMA]]) with [[psilocybin]] / [[magic mushrooms]] is termed ''hippy flipping''.''' It is thought that by combining MDMA with psilocybin this may reduce [[Adverse Psychedelic Effects|challenging experiences]] and enhances positive experiences associated with the medicine. Some evidence points to the use of low dose MDMA (50–75 mg) with psilocybin associates with significantly lower levels of total challenging experience. | '''Co-use of 3,4-Methylenedioxy methamphetamine ([[MDMA]]) with [[psilocybin]] / [[magic mushrooms]] is termed ''hippy flipping''.''' It is thought that by combining MDMA with psilocybin this may reduce [[Adverse Psychedelic Effects|challenging experiences]] and enhances positive experiences associated with the medicine. Some evidence points <ref>'''Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences'''. Richard J. Zeifman, Hannes Kettner, Broc A. Pagni, Austin Mallard, Daniel E. Roberts, David Erritzoe, Stephen Ross & Robin L. Carhart-Harris. Published: 22 August 2023. Accessed on 27th October 2023 via: https://www.nature.com/articles/s41598-023-40856-5#Sec2:~:text=Primary%20analyses-,Challenging%20experiences,high%20dose%20MDMA%20use%2C%20t(672)%E2%80%89%3D%E2%80%89%20%E2%88%92%E2%80%890.68%2C%20p%E2%80%89%3D%E2%80%890.498.,-Examining%20group%20differences</ref>to the use of low dose MDMA (50–75 mg) with psilocybin associates with significantly lower levels of total challenging experience. | ||
'''References''' | '''References''' | ||
# [[Hippy Flip#cite%20ref-1|↑]] '''Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences'''. Richard J. Zeifman, Hannes Kettner, Broc A. Pagni, Austin Mallard, Daniel E. Roberts, David Erritzoe, Stephen Ross & Robin L. Carhart-Harris. Published: 22 August 2023. Accessed on 27th October 2023 via: <nowiki>https://www.nature.com/articles/s41598-023-40856-5#Sec2:~:text=Primary%20analyses-,Challenging%20experiences,high%20dose%20MDMA%20use%2C%20t(672)%E2%80%89%3D%E2%80%89%20%E2%88%92%E2%80%890.68%2C%20p%E2%80%89%3D%E2%80%890.498.,-Examining%20group%20differences</nowiki> | # [[Hippy Flip#cite%20ref-1|↑]] '''Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences'''. Richard J. Zeifman, Hannes Kettner, Broc A. Pagni, Austin Mallard, Daniel E. Roberts, David Erritzoe, Stephen Ross & Robin L. Carhart-Harris. Published: 22 August 2023. Accessed on 27th October 2023 via: <nowiki>https://www.nature.com/articles/s41598-023-40856-5#Sec2:~:text=Primary%20analyses-,Challenging%20experiences,high%20dose%20MDMA%20use%2C%20t(672)%E2%80%89%3D%E2%80%89%20%E2%88%92%E2%80%890.68%2C%20p%E2%80%89%3D%E2%80%890.498.,-Examining%20group%20differences</nowiki> | ||
Revision as of 06:16, 27 October 2023
Co-use of 3,4-Methylenedioxy methamphetamine (MDMA) with psilocybin / magic mushrooms is termed hippy flipping. It is thought that by combining MDMA with psilocybin this may reduce challenging experiences and enhances positive experiences associated with the medicine. Some evidence points [1]to the use of low dose MDMA (50–75 mg) with psilocybin associates with significantly lower levels of total challenging experience.
References
- ↑ Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences. Richard J. Zeifman, Hannes Kettner, Broc A. Pagni, Austin Mallard, Daniel E. Roberts, David Erritzoe, Stephen Ross & Robin L. Carhart-Harris. Published: 22 August 2023. Accessed on 27th October 2023 via: https://www.nature.com/articles/s41598-023-40856-5#Sec2:~:text=Primary%20analyses-,Challenging%20experiences,high%20dose%20MDMA%20use%2C%20t(672)%E2%80%89%3D%E2%80%89%20%E2%88%92%E2%80%890.68%2C%20p%E2%80%89%3D%E2%80%890.498.,-Examining%20group%20differences
- ↑ Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences. Richard J. Zeifman, Hannes Kettner, Broc A. Pagni, Austin Mallard, Daniel E. Roberts, David Erritzoe, Stephen Ross & Robin L. Carhart-Harris. Published: 22 August 2023. Accessed on 27th October 2023 via: https://www.nature.com/articles/s41598-023-40856-5#Sec2:~:text=Primary%20analyses-,Challenging%20experiences,high%20dose%20MDMA%20use%2C%20t(672)%E2%80%89%3D%E2%80%89%20%E2%88%92%E2%80%890.68%2C%20p%E2%80%89%3D%E2%80%890.498.,-Examining%20group%20differences